Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
WASHINGTON—Dr. Richard Pazdur, a top federal drug regulator, wasn’t on board. He and lawyers from the Department of Health and Human Services objected to a press release from Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results